Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

Genome Sciences Merger

WILMINGTON, Del - Shareholders want the $3.6 billion "coercive" sale of Human Genome Sciences to GlaxoSmithKline enjoined until they have time to read the lengthy offering statements, in a federal class action.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...